HDT Bio Awarded $2.9m NIH Grant to Develop RNA Vaccine for HIV-1
HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced May 17th this year that the National Institute of Allergy and Infectious…
Tag: RNA
Fujifilm announces the Start of a New Phase III Clinical Trial of Anti-influenza Drug Avigan® Tablet in Japan, Targeting COVID-19 Patients
FUJIFILM Toyama Chemical Co., Ltd. (FUJIFILM Toyama Chemical; President: Junji Okada) has announced the initiation of a new phase III clinical trial in Japan concerning…
Scripps’ Disney Lab Breakthrough RNA-Targeting Compounds Dismantle COVID-19’s ‘Clutch’ via Disabling Reproduction Engine
Research rockstar Matthew Disney, PhD, and team from Scripps Florida have created drug-like compounds that based on results thus far in human cell studies, actually bind…
Independent Aventiv Research Selected by Pfizer & BioNTech for COVID-19 Vaccine Trial: Volunteers Drive 2 Hours to Contribute
Independently-owned Columbus Ohio-based Aventiv Research was selected by the Pfizer/BioNTech “Project Lightspeed” program to participate in the Phase 2/3 clincial trial to test the RNA-based…
Treated at University of Maryland: Could this be the First Vaccinated Person Against SARS-CoV-2?
A Maryland resident could be the first individual in the world to be vaccinated against SARS-CoV-2, the virus behind COVID-19, thanks to participation in a…
Imperial College London Making some Power Moves as they Commence Internally Developed COVID-19 Vaccine & Launch ‘Social Enterprise’
Professor Robin Shattock and team at Imperial College London initiated an important COVID-19 vaccine clinical trial recently as they prepare to administer an investigational vaccine…
FDA Clears Moderna’s mRNA-1273 for Phase II Vaccine Clinical Trial to Target 600 Participants
The U.S. Food and Drug Administration has completed its review of Moderna’s Investigational New Drug (IND) application for its SARS-CoV-2 vaccine candidate known as mRNA-1273,…
Scripps Research Institute’s Matthew Disney Secures $11 Million from NIH for RNA-Targeted Medicine Including SARS-COV-2 Targets
The National Institute of Neurological Disorders and Stroke, (NINDS) part of the National Institutes of Health (NIH) in recognition of high-impact work advancing the field…
Moderna & Harvard Inc. Strategic Preclinical Research Pact Focusing on Immunological Diseases
Moderna Inc. is a clinical-stage biotech venture pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines announced a multi-year…
UCSD-Derived Gene Therapy Technology Secures $55 Million
Bradley J. Fikes of the San Diego Union Tribune reports San Diego-based Locana has raised $55 million in venture capital funds. The biotech startup targets…